For information on the latest Parkinson’s research please visit the European Parkinson’s Disease Association website.
Horse tranquilliser trial is awarded $750,000 grant for Parkinson’s research
Author: Simge Eva DoganPublished: 26 July 2018
Prep: Cook: Serves:
Researchers at the University of Arizona College of Medicine, Tucson, US, will be trialling ketamine – a recreational drug previously used to medicate people with depression – as a treatment for Parkinson’s.
The research – led by Dr Scott Sherman – is being supported with a three-year grant of $750,000 from the Arizona Biomedical Research Commission.
The initial clinical trial will test the effect of ketamine for treating dyskinesia in 10 patients. In addition, the researchers will carry out a separate rodent study to examine how the drug affects the brain.
Dr Scott Sherman, a neurologist at the University of Arizona College of Medicine, said: “Ketamine has been long overlooked. Now it could prove very useful for Parkinson’s patients.”
For more information on this article click here.
Share this story
Alan Alda: Parkinson’s is “not the end of the world”
The US actor shares his experience of diagnosisREAD MORE
Fox Foundation offers $2m for ‘game-changing’ Parkinson’s breakthrough
Calling all researchers! $2m prize to develop imaging ‘tracer’ for keyREAD MORE
Your gym or mine: accessing specialised community Parkinson’s exercise programmes
The best exercise regime is one you stick to. Sense, or nonsense?READ MORE